down arrow

Delivra Health Brands, Inc.

  • Market Cap: Micro Cap
  • Industry: Other Agricultural Products
  • ISIN: CA24703H1029
CAD
0.24
-0.01 (-4.0%)

Dec 04

TSX

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

0.240.25

52 Week

0.110.37
Valuation
Technical
Day's Volume

CASH

6.17 k

Shareholding (Sep 2020)

FII

0.02%

Held by 1 FIIs

DII

99.98%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Risky -

  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 42.86%, its profits have fallen by -9%
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Other Agricultural Products

stock-summary
Market cap

CAD 8 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.28

stock-summary
Return on Equity

-25.55%

stock-summary
Price to Book

1.92

Revenue and Profits:
Net Sales:
3 Million
(Quarterly Results - Mar 2025)
Net Profit:
0 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
20.0%
0%
20.0%
6 Months
0%
0%
0.0%
1 Year
37.14%
0%
37.14%
2 Years
60.0%
0%
60.0%
3 Years
860.0%
0%
860.0%
4 Years
242.86%
0%
242.86%
5 Years
220.0%
0%
220.0%

Delivra Health Brands, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
1.88%
EBIT Growth (5y)
14.53%
EBIT to Interest (avg)
-5.40
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.30
Sales to Capital Employed (avg)
1.98
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.73
EV to EBIT
-6.16
EV to EBITDA
6.16
EV to Capital Employed
2.02
EV to Sales
0.46
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-27.64%
ROE (Latest)
-25.55%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2020stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.02%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is 10.71% vs -12.50% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is 50.00% vs -60.00% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3.10",
          "val2": "2.80",
          "chgp": "10.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.00",
          "val2": "-0.30",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.10",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.40",
          "val2": "-0.80",
          "chgp": "50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-91.10%",
          "val2": "-234.90%",
          "chgp": "14.38%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Jun'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Jun 2024 is 26.53% vs 20.99% in Jun 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Jun 2024 is 550.00% vs 97.14% in Jun 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'24",
        "Jun'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "12.40",
          "val2": "9.80",
          "chgp": "26.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.60",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.30",
          "chgp": "-33.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.90",
          "val2": "0.90",
          "chgp": "111.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.90",
          "val2": "-0.20",
          "chgp": "550.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-57.40%",
          "val2": "-139.20%",
          "chgp": "8.18%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQstock-summary
Mar'25
Dec'24
Change(%)
Net Sales
3.10
2.80
10.71%
Operating Profit (PBDIT) excl Other Income
0.00
-0.30
100.00%
Interest
0.10
0.10
Exceptional Items
0.00
-0.10
100.00%
Consolidate Net Profit
-0.40
-0.80
50.00%
Operating Profit Margin (Excl OI)
-91.10%
-234.90%
14.38%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2025 is 10.71% vs -12.50% in Dec 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Mar 2025 is 50.00% vs -60.00% in Dec 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Jun'24stock-summary
Jun'24
Jun'23
Change(%)
Net Sales
12.40
9.80
26.53%
Operating Profit (PBDIT) excl Other Income
0.60
-0.00
Interest
0.20
0.30
-33.33%
Exceptional Items
1.90
0.90
111.11%
Consolidate Net Profit
0.90
-0.20
550.00%
Operating Profit Margin (Excl OI)
-57.40%
-139.20%
8.18%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Jun 2024 is 26.53% vs 20.99% in Jun 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Jun 2024 is 550.00% vs 97.14% in Jun 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Delivra Health Brands, Inc. stock-summary
stock-summary
Delivra Health Brands, Inc.
Other Agricultural Products
Harvest One Cannabis Inc.(Harvest One) is a Canada-based company that develops and distributes health, wellness and selfcare products with a market focus on sleep, pain, and anxiety. The Company's subsidiaries include Satipharm Limited (Satipharm), Dream Water Global, and Delivra Corp. (Delivra). Satipharm is a health & wellbeing company, which is specialized in the development and manufacture of cannabinoid-based products from the cannabis plant. Dream Water Global is engaged in selling natural, 0-calorie, liquid sleep shot. Delivra manufactures and sells a line of natural topical creams with the transdermal delivery system platform under the LivRelief brand, for conditions such as joint and muscle pain, nerve pain, varicose veins, wound healing, and sports performance.
Company Coordinates stock-summary
Company Details
Suite 404, 999 Canada Place , VANCOUVER BC : V6C 3E2
stock-summary
Tel: 1 604 4499280
stock-summary
https://www.harvestone.com
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."